Press "Enter" to skip to content

STORM Therapeutics Extends Series A to GBP 30M (USD 38.43M) with New Investor, Seroba Life Sciences – PRNewswire

admin 0

STORM Therapeutics Extends Series A to GBP 30M (USD 38.43M) with New Investor, Seroba Life Sciences  PRNewswire

CAMBRIDGE, England, May 20, 2019 /PRNewswire/ — STORM Therapeutics (“STORM”), the drug discovery company tackling disease through modulating RNA …

“liver cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *